• FPR2/ALX in Autoimmune Astrocytopathy

  2026-08-31

  A 2026 study shows that activating FPR2/ALX with Quin-C1 limits AQP4-IgG- and complement-associated astrocytopathy in mice by reshaping microglial and natural killer cell responses. Its depletion and pathway-inhibition experiments identify microglia, NK cells, and SYK-AKT signaling as important components of the protective phenotype, while also highlighting limitations for translation to human NMOSD.

• DON Liver Injury: Mitophagy and Nrf2 Suppression

  2026-08-31

  This reference study proposes that deoxynivalenol causes liver injury through excessive PINK1/Parkin-mediated mitophagy coupled with suppression of the p62-Keap1-Nrf2 antioxidant pathway. Mouse and AML-12 cell experiments, including PINK1 inhibition and p62 rescue, connect mitochondrial damage with apoptosis, oxidative stress, inflammation, and lipid dysregulation while defining testable intervention points.

• Maternal Surgery, Calpain, and Offspring Cognition

  2026-08-30

  A 2025 Neuropharmacology study identifies excessive calpain activity as a mechanistic link between maternal non-obstetric surgery during pregnancy and cognitive deficits in offspring. Using postnatal MDL 28170 and a TrkB agonist as pharmacological probes, the researchers connect impaired BDNF/TrkB signaling with hippocampal synaptic and neuronal abnormalities.

• Carbapenemase Gene Transmission in CREC

  2026-08-29

  A 2025 BMC Microbiology study integrated gene localization, antimicrobial susceptibility, conjugation, mobile genetic elements, and strain genotyping to characterize carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong. Its findings indicate that blaNDM-1 was frequently plasmid-associated and highly transferable, providing a practical framework for interpreting multidrug resistance and healthcare transmission risk.

• One-step TUNEL Cy3 Apoptosis Detection Kit Guide

  2026-08-28

  Use the One-step TUNEL Cy3 Apoptosis Detection Kit to visualize apoptotic DNA fragmentation in cultured cells, frozen sections, and paraffin-embedded tissues. This guide connects assay design, quantitative imaging, flow cytometry, and CRC drug-response workflows with practical controls and troubleshooting.

• HBTU and the Translational Logic of Selective Peptides

  2026-08-28

  Enzyme-responsive peptide therapeutics illustrate why molecular design and synthesis quality must be planned together. This thought-leadership article connects the dual enzyme-responsive zwitterionic peptide study with the mechanistic role of HBTU in carboxylic acid activation, peptide bond formation, and solid phase peptide synthesis. It also provides workflow parameters, translational boundaries, and a strategic framework for using HBTU as a process-control tool rather than treating coupling chemistry as a commodity step.

• QSHXO in MASLD: Autophagy and Ferroptosis

  2026-08-27

  A 2026 World Journal of Hepatology study reports that Qushi Huoxue ointment reduces hepatic lipid deposition and inflammation in a mouse model of metabolic associated steatotic liver disease. Its key contribution is a coordinated mechanistic model linking enhanced autophagic flux with Nrf2-associated suppression of ferroptosis, while also identifying important limitations for translation beyond the experimental model.

• (S)-(+)-Dimethindene maleate: M2 Workflow

  2026-08-27

  This guide presents (S)-(+)-Dimethindene maleate as a research probe for separating M2 muscarinic receptor activity from broader muscarinic and histamine H1 effects. It focuses on reagent preparation, selectivity controls, and assay QC; it should not be used for diagnosis, treatment, or clinical decision-making.

• GANT61 for Reproducible GLI Assays

  2026-08-26

  This scenario-based guide explains how GANT61 (SKU A1615) can improve the design, handling, and interpretation of GLI-dependent cell viability and proliferation experiments. It connects product specifications with recent GLI2–ferroptosis findings while separating validated evidence from practical workflow recommendations.

• BMS 309403: A Causal Map of FABP4 Biology

  2026-08-26

  BMS 309403 is a potent FABP4 inhibitor for dissecting how lipid trafficking connects inflammation, foam cell formation, and metabolic dysfunction. This article translates recent SERCA2–calcineurin–FoxO1–FABP4 findings into a practical framework for selecting assays and interpreting pharmacological rescue.

• Viral RIPK3 Degradation Controls Inflammation

  2026-08-25

  Liu and colleagues identified vIRD, a viral inducer that recruits SCF ubiquitin machinery to promote proteasomal degradation of RIPK3 and suppress necroptosis. The study shows that this immune-evasion strategy can paradoxically increase orthopoxvirus replication, inflammation, and mortality by reshaping the balance between host cell death and antiviral defense.

• Higher-Concentration LNPs Improve mRNA Delivery

  2026-08-25

  The reference study shows that intensified confined jet-impingement mixing can produce mRNA-loaded lipid nanoparticles from substantially more concentrated lipid and RNA starting materials without sacrificing key particle attributes. Higher-concentration formulations also improved in vivo expression, biodistribution, and storage performance, although buffer composition remained a critical determinant of biological outcome.

• TRPV1 and TRPA1: Bifurcated ROS Sensing

  2026-08-24

  The reference study shows that TRPV1 and TRPA1 distinguish singlet oxygen from hydrogen peroxide through different chemical and functional mechanisms. Its findings position Carvacrol as a useful non-electrophilic TRPA1 agonist for separating redox-dependent channel modification from agonist-specific signaling, while also defining important limits on how these results should be interpreted in cell cycle or apoptosis research.

• Idoxuridine for Viral DNA Assay Design

  2026-08-24

  Idoxuridine provides a practical way to probe viral DNA synthesis, replication timing, and nucleoside-analog sensitivity in cell-based assays. This guide combines formulation, infection workflows, orthogonal readouts, and a cautious cross-domain lesson from human DRG research.

• Angiotensin (1-7) Research Workflow Guide

  2026-08-23

  Build more interpretable Angiotensin (1-7) experiments by connecting Mas receptor biology with practical cell, enzymology, and preclinical workflows. This guide emphasizes peptide handling, assay controls, pathway-focused readouts, and troubleshooting for renal, inflammatory, metabolic, and neurovascular research.

8086 records 1/540 page Next 12345 下5页 Last page